Home › Funds › WATERS PARKERSON & CO., LLC › ABT

WATERS PARKERSON & CO., LLC position in ABT

ABBOTT LABORATORIES · Health Care

WATERS PARKERSON & CO., LLC reported holding 488,215 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$48.3M, representing 2.32% of its reported portfolio and ranking #15 among its reported holdings. WATERS PARKERSON & CO., LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)488.21K sh
Reported value held$48.25M
Portfolio Weight2.32%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How WATERS PARKERSON & CO., LLC's ABT position evolved

WATERS PARKERSON & CO., LLC first disclosed a stake in ABT in Q3 2023 at 479,607 shares (US$46.5M). The position peaked in Q2 2025 at 457,727 shares, worth US$62.3M. Across 13 filings, WATERS PARKERSON & CO., LLC increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 488,215 shares valued at US$48.3M — an increase of 10,275 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 479.61K $46.45M New
Q4 2023 473.09K $52.07M Reduce
Q1 2024 466.73K $53.05M Reduce
Q2 2024 468.94K $48.73M Hold
Q3 2024 466.41K $53.18M Reduce
Q4 2024 464.31K $52.52M Hold
Q1 2025 457.86K $60.74M Reduce
Q2 2025 457.73K $62.26M Hold
Q3 2025 460.17K $61.64M Add
Q4 2025 458.82K $57.49M Hold
Q1 2026 462.36K $47.47M Add
Q2 2026 477.94K $43.37M Add
Q3 2026 488.21K $48.25M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has WATERS PARKERSON & CO., LLC held ABT?

WATERS PARKERSON & CO., LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is WATERS PARKERSON & CO., LLC's current position in ABT?

As of Q3 2026, WATERS PARKERSON & CO., LLC holds 488.21K shares of ABT (ABBOTT LABORATORIES), valued at $48.25M, representing 2.32% of its reported portfolio and ranking #15.

Has WATERS PARKERSON & CO., LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), WATERS PARKERSON & CO., LLC increased its position in ABT. The position peaked in Q2 2025 at 457.73K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.